CIK: 0001634557
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | Stock-Healthcare | 29.45% | — | -2.81% | |
| 2 | PRTA | Prothena Corporation plc | Stock-Other | 25.64% | — | +7.72% | |
| 3 | ALKS | Alkermes plc | Stock-Healthcare | 18.09% | — | +0.26% | |
| 4 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 16.31% | -71.30% | EXIT | |
| 5 | GILD | Gilead Sciences INC | Stock-Healthcare | 4.47% | — | +158.52% | |
| 6 | BIIB | Biogen INC | Stock-Healthcare | 4.26% | — | +51.61% | |
| 7 | ✓ | Bioverativ Inc | Stock-Other | 1.78% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GILD | Gilead Sciences INC | +2.4% | +158.52% | Add |
| 2 | PRTA | Prothena Corporation plc | +1.2% | +7.72% | Add |
| 3 | BIIB | Biogen INC | +1.1% | +51.61% | Add |
| 4 | TBPH | Theravance Biopharma, Inc. | +0.2% | +1.88% | Add |
| 5 | ALKS | Alkermes plc | -1.9% | +0.26% | Add |
| 6 | ABBV | Abbvie INC | -4.4% | -2.81% | Trim |
| 7 | ✓ | Bioverativ Inc | — | NEW | New buy |
| 8 | NWBO | Northwest Biotherapeutics | — | EXIT | Sold out |